MD · PhD · Clinical research · Founder

Turning medical ideas into research, products and patient routes

Artem Nikolaevich Poltoratskiy is a medical oncologist, Doctor of Medical Sciences and clinical-research leader working at the intersection of oncology, patient navigation and medical technology.

Artem Poltoratskiy in a professional research discussion
Medicine · research · implementation
Since 2012continuous leadership of oncology research processes
82clinical studies listed in the official GRLS investigator profile
MIKA.helppatient navigation and clinical-trial discovery
Trialecodigital clinical-research ecosystem

Core work

One professional profile, four connected areas

Clinical practice creates the questions; research, patient navigation and technology turn them into repeatable solutions.

01

Clinical research

Principal-investigator leadership, protocol feasibility, research-team organisation, patient access and quality-focused study conduct.

For sponsors and CROs
02

Patient navigation

Plain-language diagnosis guides and a structured search of public clinical-trial records without collecting personal data in the search interface.

For patients and families
03

Medical technology

Clinical strategy, validation planning and pilot design for health-tech teams moving from a useful idea to a responsible medical workflow.

For health-tech teams
04

Public and professional dialogue

Talks, webinars and professional discussions on oncology, clinical trials, medical AI and healthy longevity.

About Artem

Projects

Research, services and products in one clear portfolio

Clinical research, patient navigation, medical technology, products and public initiatives are separated by type, maturity, role and evidence boundary.

View all projects →

Evidence and perspective

Long-form, source-linked analysis

English articles explain clinical research, patient search, responsible medical AI, product development and healthy longevity without replacing professional advice.

How to find a clinical trial

Discovery, locations, eligibility and direct site confirmation—kept as separate evidence layers.

Read the guide

How a modern research team works

Evidence-based feasibility, recruitment, training, quality by design and sponsor communication.

Read the methodology

GCP, GLP and GMP explained

Three quality systems, their different roles and the claims that each one cannot support on its own.

Compare the standards

Preclinical drug development

Pharmacology, exposure, toxicology, CMC and the evidence needed before clinical development.

Read the guide

AI in medicine

Where AI can support clinical work, which limits matter and why accountable human oversight is essential.

Read the analysis

Scientific publications

A source-linked bibliography of PubMed records associated with Artem Poltoratskiy.

Open bibliography

Work together

Choose the right professional route

Three direct routes for sponsors, technology teams and event organisers. Patient information remains in its own protected context.

For pharma companies and CROs

Protocol-specific feasibility, patient-access assumptions, research-team organisation and a current site profile on request.

Open the sponsor page

For health-tech companies

Clinical problem framing, validation strategy and responsible implementation of medical and AI-enabled products.

Open the health-tech page

Invite Artem to speak

Oncology, clinical trials, patient navigation, medical technology, responsible AI and healthy longevity.

Send an invitation

Next step

Start with a clear question

For a non-confidential initial enquiry about research, partnership, a health-tech product or a media invitation, contact the team by email or Telegram.